Skip to main content
. 2019 Sep 23;11(18):7817–7829. doi: 10.18632/aging.102290

Figure 1.

Figure 1

Expression of PRL-3 and stathmin in clinical samples and cell lines detected by western blot. (AC) Expression of PRL-3 and stathmin in de novo myeloid leukemia patients. (D, E) Expression of PRL-3 and stathmin in myeloid leukemia cell lines. (*P<0.05, **P<0.01, vs. healthy normal control). Note: N, healthy normal control. P, de novo patient.